Eladio Flores Sanchez

Title: Eladio Flores Sanchez: Innovator in Thrombolytic Agents

Introduction

Eladio Flores Sanchez is a notable inventor based in Belo Horizonte, Brazil. He has made significant contributions to the field of thrombolytic agents, particularly through his innovative patent that addresses the treatment of blood clots. His work is essential in advancing medical therapies aimed at alleviating conditions caused by thrombi.

Latest Patents

Eladio Flores Sanchez holds a patent for "Thrombolytic agents with antithrombotic activity." This invention provides thrombolytic agents and methods for making and using these agents. Specifically, it includes thrombolytic agents comprising a thrombolytic proteinase and a specific binding peptide that binds at the site of blood clots and thrombi in vivo. The invention particularly features chemically crosslinked conjugates of a thrombolytic proteinase and a plurality of specific binding peptides. Methods for producing these conjugates and their application for eliminating thrombi in vivo are also included. The preferred thrombolytic proteinase in the conjugate is fibrolase, which can be obtained from Agkistrodon contortrix confortrix venom. He has 1 patent to his name.

Career Highlights

Eladio Flores Sanchez is associated with Diatide, Inc., where he continues to contribute to the field of medical innovations. His work has the potential to significantly impact the treatment of thrombotic conditions, showcasing his dedication to improving healthcare outcomes.

Collaborations

Throughout his career, Eladio has collaborated with esteemed colleagues such as Francis S Markland, Jr. and Larry R Bush. These collaborations have likely enriched his research and development efforts, leading to advancements in thrombolytic therapies.

Conclusion

Eladio Flores Sanchez is a prominent inventor whose work in thrombolytic agents is paving the way for innovative medical treatments. His contributions are vital in the ongoing fight against thrombotic diseases, and his patent reflects a significant advancement in this critical area of healthcare.